184 related articles for article (PubMed ID: 26964624)
1. Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer.
Johnson N; De Ieso P; Migliorini G; Orr N; Broderick P; Catovsky D; Matakidou A; Eisen T; Goldsmith C; Dudbridge F; Peto J; Dos-Santos-Silva I; Ashworth A; Ross G; Houlston RS; Fletcher O
Cancer Res; 2016 Mar; 76(6):1485-1493. PubMed ID: 26964624
[TBL] [Abstract][Full Text] [Related]
2. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.
Johnson N; Maguire S; Morra A; Kapoor PM; Tomczyk K; Jones ME; Schoemaker MJ; Gilham C; Bolla MK; Wang Q; Dennis J; Ahearn TU; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Aronson KJ; Augustinsson A; Baynes C; Freeman LEB; Beckmann MW; Benitez J; Bermisheva M; Blomqvist C; Boeckx B; Bogdanova NV; Bojesen SE; Brauch H; Brenner H; Burwinkel B; Campa D; Canzian F; Castelao JE; Chanock SJ; Chenevix-Trench G; Clarke CL; ; Conroy DM; Couch FJ; Cox A; Cross SS; Czene K; Dörk T; Eliassen AH; Engel C; Evans DG; Fasching PA; Figueroa J; Floris G; Flyger H; Gago-Dominguez M; Gapstur SM; García-Closas M; Gaudet MM; Giles GG; Goldberg MS; González-Neira A; ; Guénel P; Hahnen E; Haiman CA; Håkansson N; Hall P; Hamann U; Harrington PA; Hart SN; Hooning MJ; Hopper JL; Howell A; Hunter DJ; ; ; Jager A; Jakubowska A; John EM; Kaaks R; Keeman R; Khusnutdinova E; Kitahara CM; Kosma VM; Koutros S; Kraft P; Kristensen VN; Kurian AW; Lambrechts D; Le Marchand L; Linet M; Lubiński J; Mannermaa A; Manoukian S; Margolin S; Martens JWM; Mavroudis D; Mayes R; Meindl A; Milne RL; Neuhausen SL; Nevanlinna H; Newman WG; Nielsen SF; Nordestgaard BG; Obi N; Olshan AF; Olson JE; Olsson H; Orban E; Park-Simon TW; Peterlongo P; Plaseska-Karanfilska D; Pylkäs K; Rennert G; Rennert HS; Ruddy KJ; Saloustros E; Sandler DP; Sawyer EJ; Schmutzler RK; Scott C; Shu XO; Simard J; Smichkoska S; Sohn C; Southey MC; Spinelli JJ; Stone J; Tamimi RM; Taylor JA; Tollenaar RAEM; Tomlinson I; Troester MA; Truong T; Vachon CM; van Veen EM; Wang SS; Weinberg CR; Wendt C; Wildiers H; Winqvist R; Wolk A; Zheng W; Ziogas A; Dunning AM; Pharoah PDP; Easton DF; Howie AF; Peto J; Dos-Santos-Silva I; Swerdlow AJ; Chang-Claude J; Schmidt MK; Orr N; Fletcher O
Br J Cancer; 2021 Feb; 124(4):842-854. PubMed ID: 33495599
[TBL] [Abstract][Full Text] [Related]
3. Genetic contribution to variable human CYP3A-mediated metabolism.
Lamba JK; Lin YS; Schuetz EG; Thummel KE
Adv Drug Deliv Rev; 2002 Nov; 54(10):1271-94. PubMed ID: 12406645
[TBL] [Abstract][Full Text] [Related]
4. CYP3A variation, premenopausal estrone levels, and breast cancer risk.
Johnson N; Walker K; Gibson LJ; Orr N; Folkerd E; Haynes B; Palles C; Coupland B; Schoemaker M; Jones M; Broderick P; Sawyer E; Kerin M; Tomlinson IP; Zvelebil M; Chilcott-Burns S; Tomczyk K; Simpson G; Williamson J; Hillier SG; Ross G; Houlston RS; Swerdlow A; Ashworth A; Dowsett M; Peto J; Dos Santos Silva I; Fletcher O
J Natl Cancer Inst; 2012 May; 104(9):657-69. PubMed ID: 22472546
[TBL] [Abstract][Full Text] [Related]
5. A common polymorphism in the CYP3A7 gene is associated with a nearly 50% reduction in serum dehydroepiandrosterone sulfate levels.
Smit P; van Schaik RH; van der Werf M; van den Beld AW; Koper JW; Lindemans J; Pols HA; Brinkmann AO; de Jong FH; Lamberts SW
J Clin Endocrinol Metab; 2005 Sep; 90(9):5313-6. PubMed ID: 15985487
[TBL] [Abstract][Full Text] [Related]
6. CYP3A7*1C allele is associated with reduced levels of 2-hydroxylation pathway oestrogen metabolites.
Sood D; Johnson N; Jain P; Siskos AP; Bennett M; Gilham C; Busana MC; Peto J; Dos-Santos-Silva I; Keun HC; Fletcher O
Br J Cancer; 2017 Jan; 116(3):382-388. PubMed ID: 28072767
[TBL] [Abstract][Full Text] [Related]
7. CYP3A7 protein expression is high in a fraction of adult human livers and partially associated with the CYP3A7*1C allele.
Sim SC; Edwards RJ; Boobis AR; Ingelman-Sundberg M
Pharmacogenet Genomics; 2005 Sep; 15(9):625-31. PubMed ID: 16041241
[TBL] [Abstract][Full Text] [Related]
8. Identification of a null allele of cytochrome P450 3A7: CYP3A7 polymorphism in a Korean population.
Lee SS; Jung HJ; Park JS; Cha IJ; Cho DY; Shin JG
Mol Biol Rep; 2010 Jan; 37(1):213-7. PubMed ID: 19585271
[TBL] [Abstract][Full Text] [Related]
9. Identification and phenotype characterization of two CYP3A haplotypes causing different enzymatic capacity in fetal livers.
Rodríguez-Antona C; Jande M; Rane A; Ingelman-Sundberg M
Clin Pharmacol Ther; 2005 Apr; 77(4):259-70. PubMed ID: 15903124
[TBL] [Abstract][Full Text] [Related]
10. CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients.
Crettol S; Venetz JP; Fontana M; Aubert JD; Pascual M; Eap CB
Ther Drug Monit; 2008 Dec; 30(6):689-99. PubMed ID: 18978522
[TBL] [Abstract][Full Text] [Related]
11. Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome.
Goodarzi MO; Xu N; Azziz R
J Clin Endocrinol Metab; 2008 Jul; 93(7):2909-12. PubMed ID: 18445661
[TBL] [Abstract][Full Text] [Related]
12. CYP3A7*1C polymorphism, serum dehydroepiandrosterone sulfate level, and bone mineral density in postmenopausal women.
Bácsi K; Kósa JP; Borgulya G; Balla B; Lazáry A; Nagy Z; Horváth C; Speer G; Lakatos P
Calcif Tissue Int; 2007 Mar; 80(3):154-9. PubMed ID: 17334880
[TBL] [Abstract][Full Text] [Related]
13. [Impact of CYP3A7*1C polymorphism on bone mineral content in postmenopausal women].
Bácsi K; Kósa J; Lazáry A; Balla B; Horváth H; Takács I; Nagy Z; Speer G; Lakatos P
Orv Hetil; 2007 Jul; 148(27):1273-80. PubMed ID: 17604264
[TBL] [Abstract][Full Text] [Related]
14. Screening for SNPs and haplotypes in the CYP3A7 gene in Chinese populations.
Du J; Shi Y; Zhang A; Wang L; Xuan J; He G; Xu L; Xu M; Shu A; Yu L; Li X; Meng J; Feng G; Xing Q; He L
Pharmacogenomics; 2007 Jun; 8(6):559-66. PubMed ID: 17559345
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine.
Burk O; Tegude H; Koch I; Hustert E; Wolbold R; Glaeser H; Klein K; Fromm MF; Nuessler AK; Neuhaus P; Zanger UM; Eichelbaum M; Wojnowski L
J Biol Chem; 2002 Jul; 277(27):24280-8. PubMed ID: 11940601
[TBL] [Abstract][Full Text] [Related]
16. A novel polymorphic cytochrome P450 formed by splicing of CYP3A7 and the pseudogene CYP3AP1.
Rodriguez-Antona C; Axelson M; Otter C; Rane A; Ingelman-Sundberg M
J Biol Chem; 2005 Aug; 280(31):28324-31. PubMed ID: 15937338
[TBL] [Abstract][Full Text] [Related]
17. CYP1A1, CYP3A5 and CYP3A7 polymorphisms and testicular cancer susceptibility.
Kristiansen W; Haugen TB; Witczak O; Andersen JM; Fosså SD; Aschim EL
Int J Androl; 2011 Feb; 34(1):77-83. PubMed ID: 20345875
[TBL] [Abstract][Full Text] [Related]
18. Allele and genotype frequencies of CYP3A4, CYP3A5, CYP3A7, and GSTP1 gene polymorphisms among mainland Tibetan, Mongolian, Uyghur, and Han Chinese populations.
Qi G; Han C; Zhou Y; Wang X
Clin Exp Pharmacol Physiol; 2022 Feb; 49(2):219-227. PubMed ID: 34689350
[TBL] [Abstract][Full Text] [Related]
19. TP53 Gene 72 Arg/Pro (rs1042522) Single Nucleotide Polymorphism Contribute to Increase the Risk of B-Chronic Lymphocytic Leukemia in the Sudanese Population.
Mohammed Basabaeen AA; Abdelgader EA; Babekir EA; Abdelrahim SO; Eltayeb NH; Altayeb OA; Fadul EA; Sabo A; Ibrahim IK
Asian Pac J Cancer Prev; 2019 May; 20(5):1579-1585. PubMed ID: 31128065
[TBL] [Abstract][Full Text] [Related]
20. Ethnic differences between Japanese and Caucasians in the expression levels of mRNAs for CYP3A4, CYP3A5 and CYP3A7: lack of co-regulation of the expression of CYP3A in Japanese livers.
Yamaori S; Yamazaki H; Iwano S; Kiyotani K; Matsumura K; Saito T; Parkinson A; Nakagawa K; Kamataki T
Xenobiotica; 2005 Jan; 35(1):69-83. PubMed ID: 15788369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
